ES435067A1 - Procedimiento para la preparacion de nuevos esteroides. - Google Patents

Procedimiento para la preparacion de nuevos esteroides.

Info

Publication number
ES435067A1
ES435067A1 ES435067A ES435067A ES435067A1 ES 435067 A1 ES435067 A1 ES 435067A1 ES 435067 A ES435067 A ES 435067A ES 435067 A ES435067 A ES 435067A ES 435067 A1 ES435067 A1 ES 435067A1
Authority
ES
Spain
Prior art keywords
formula
fluoro
diene
bromo
pregna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES435067A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierrel SpA
Original Assignee
Pierrel SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel SpA filed Critical Pierrel SpA
Publication of ES435067A1 publication Critical patent/ES435067A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES435067A 1974-02-27 1975-02-25 Procedimiento para la preparacion de nuevos esteroides. Expired ES435067A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8928/74A GB1499822A (en) 1974-02-27 1974-02-27 2-bromo-6beta-fluoropregna-1,4-diene-3,20-diones
GB2998474 1974-07-05
GB3294574 1974-07-25
GB4998274 1974-11-19

Publications (1)

Publication Number Publication Date
ES435067A1 true ES435067A1 (es) 1977-07-01

Family

ID=27447687

Family Applications (3)

Application Number Title Priority Date Filing Date
ES435067A Expired ES435067A1 (es) 1974-02-27 1975-02-25 Procedimiento para la preparacion de nuevos esteroides.
ES455934A Expired ES455934A1 (es) 1974-02-27 1977-02-15 Procedimiento para la preparacion de nuevos esteroides.
ES455933A Expired ES455933A1 (es) 1974-02-27 1977-02-15 Procedimiento para la preparacion de nuevos esteroides.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES455934A Expired ES455934A1 (es) 1974-02-27 1977-02-15 Procedimiento para la preparacion de nuevos esteroides.
ES455933A Expired ES455933A1 (es) 1974-02-27 1977-02-15 Procedimiento para la preparacion de nuevos esteroides.

Country Status (18)

Country Link
JP (1) JPS5614677B2 (es)
AR (1) AR218601A1 (es)
BE (1) BE826030A (es)
CA (1) CA1064476A (es)
CH (1) CH608243A5 (es)
DE (3) DE2508136C3 (es)
DK (1) DK144068C (es)
ES (3) ES435067A1 (es)
FI (1) FI56188C (es)
FR (1) FR2261776B1 (es)
GB (1) GB1499822A (es)
IE (1) IE42112B1 (es)
LU (1) LU71908A1 (es)
NO (1) NO144527C (es)
NZ (1) NZ176716A (es)
RO (1) RO78881A (es)
SE (1) SE410736B (es)
YU (3) YU108381A (es)

Also Published As

Publication number Publication date
IE42112L (en) 1975-08-27
DE2508136B2 (de) 1978-11-02
NO144527C (no) 1981-09-23
NZ176716A (en) 1978-07-10
SE7502146L (es) 1975-08-28
DE2533377B2 (de) 1978-11-16
CA1064476A (en) 1979-10-16
NO750633L (es) 1975-08-28
JPS50126652A (es) 1975-10-04
FR2261776B1 (es) 1978-07-21
DE2533323B2 (de) 1978-11-16
ES455934A1 (es) 1978-05-01
AR218601A1 (es) 1980-06-30
RO78881A (ro) 1982-07-06
FI56188B (fi) 1979-08-31
FR2261776A1 (es) 1975-09-19
DE2508136C3 (de) 1979-06-21
DK61575A (es) 1975-10-27
CH608243A5 (en) 1978-12-29
DK144068B (da) 1981-11-30
YU108281A (en) 1982-02-28
DE2508136A1 (de) 1975-10-30
SE410736B (sv) 1979-10-29
GB1499822A (en) 1978-02-01
DK144068C (da) 1982-05-03
DE2533323C3 (de) 1979-07-12
LU71908A1 (es) 1975-06-24
FI750537A (es) 1975-08-28
YU108381A (en) 1982-02-28
JPS5614677B2 (es) 1981-04-06
DE2533323A1 (de) 1976-02-12
DE2533377C3 (de) 1979-08-02
ES455933A1 (es) 1978-05-01
BE826030A (fr) 1975-06-16
NO144527B (no) 1981-06-09
IE42112B1 (en) 1980-06-04
FI56188C (fi) 1979-12-10
YU108481A (en) 1982-02-28
DE2533377A1 (de) 1976-02-05

Similar Documents

Publication Publication Date Title
NO164905C (no) Fremgangsmaate for fremstilling av 16,17-acetal-pregnanderivater.
JPS54128560A (en) Hydrocortisone derivative
GB902294A (en) Improvements in or relating to steroids and the manufacture thereof
ES435067A1 (es) Procedimiento para la preparacion de nuevos esteroides.
GB1440064A (en) Delta8-9- steroids of the pregnane series
GB1060793A (en) Improvements in or relating to steroids and the manufacture thereof
GB898295A (en) Improvements in or relating to steroids and the manufacture thereof
GB1043995A (en) Improvements in or relating to 5,10-methylene-19-nor-steroids and 5,10-seco-5,19-cyclo-10-fluoro-steroids
GB843215A (en) Improvements in or relating to steroid compounds
GB970482A (en) New 17-desoxy corticosteroids and processes for their preparation
GB892620A (en) Cyclopentanophenanthrene derivatives
SE8400145L (sv) Forfarande for framstellning av 17-estrar av klobetasol
US3485854A (en) 16beta-methyl-9beta-fluoro-steroids
US3089873A (en) 16alpha-alkoxycorticoids
JPS54130548A (en) Prednisolone derivative
GB1308673A (en) 21-halogeno-steroids
GB959792A (en) Improvements in or relating to steroids
GB1101119A (en) 2ª‡-aminocarbonyl steroids
ES265581A1 (es) Un procedimiento de preparaciën de derivados del pregnano
GB965292A (en) Halogenated steroid derivatives
JPS52144663A (en) Preparation of pregnane steroid 17alpha-ester 21-halides
GB806045A (en) Steroids
ES435527A1 (es) Un procedimiento para la preparacion de esteres 16 a -ob 16-metil-9 a-cloro o fluroesteroides de elevada actividad to- pica.
SE423903B (sv) Forfarande for framstellning av 9 alfa, 21-dihalogen-11 beta,17 alfa-dihydroxi-6 alfa-flour-16 alfa-metyl-pregna-1,4-dien-3,20-dion-estrar
Gadsby et al. Eniminium salts as protecting groups in steroid synthesis